查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439280

無針注射-全球市場考量、競爭格局、市場預測（2030）

Needle Free Injections - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球無針注射系統市場規模預計2023年將達到124.9億美元，2030年將達到276.5億美元，2024-2030年預測期間複合年增長率為14.16%。由於慢性病盛行率上升、針刺傷普遍存在、自我注射器需求增加、疫苗接種計畫增加以及產品開發中的技術創新等因素，無針注射系統的需求呈現成長趨勢。

無針注射市場動態

無針注射技術包括結合不同模式並利用壓力進行皮下給藥的藥物輸送系統，因此無需皮下注射針。

影響無針注射市場成長的主要因素之一是患者和照護者中針刺傷的數量不斷增加。根據世界衛生組織（WHO）（2019）提供的數據，全球每年有 3,500 萬名醫護人員遭受超過 200 萬次職業針刺傷害。

根據美國疾病管制與預防中心 (CDC) 和歐盟職業安全與健康管理局 2019 年的報告，美國和歐洲醫院醫護人員的針刺傷病例超過 385,000 例，每年超過 100 萬例， 分別。

針刺傷會增加 20 多種血液傳染感染的風險，包括 HIV、C型肝炎和B型肝炎。除了傳播血源性病原體外，針刺傷還會導致慢性疾病，還會產生心理影響。此外，處理針刺和尖銳傷口的成本很高。因此，由於上述因素，市場對無針注射系統的需求不斷增加，這種系統不僅可以改善醫療保健提供者、護理人員和患者的安全前景，而且還可以安全地進行藥物和治療。

此外，糖尿病等慢性病盛行率的上升也是促進無針注射市場成長的主要因素之一。

根據IDF Diabetes Atlas（2023 年）的統計，2021 年有 5.37 億成年人患有糖尿病。預計到 2030 年，這一數字將增至 6.43 億，到 2045 年將增至 7.83 億。糖尿病患者需要定期服用胰島素作為主要治療方法之一。許多醣尿病患者每天需要多次劑量的胰島素，並且經常經歷與注射相關的焦慮和疼痛。無針注射提供了一種幾乎無痛的方式來準確地自我注射胰島素，從而提高患者對治療的依從性和依從性。

此外，對大部分人口提供 COVID-19 疫苗的高度關注也導致對無針注射器的需求增加。

因此，慢性病盛行率的上升、針刺傷害的增加以及對更安全的自我注射器的需求不斷增長預計將推動無針注射市場的成長。

然而，對培訓和設備維護的更高要求、給藥途徑的限制以及設計尺寸變化的限制可能是無針注射市場成長的某些限制因素。

無針注射細分市場分析

在無針注射器市場的應用領域，用於胰島素輸送的無針注射器預計將在預測期內佔據重要份額。這是由於全世界糖尿病盛行率不斷上升。

糖尿病患者每天需要多次服用胰島素，但使用傳統注射器和針頭注射胰島素對患者來說可能是一項艱鉅的任務。這些裝置有助於透過噴嘴孔輕鬆注射胰島素，從而產生細小的胰島素流。這種水流很容易穿透皮膚。

本報告提供了全球無針注射市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章 無針注射市場報告簡介

第二章無針注射市場概要

  • 調查範圍
  • 市場概況
  • 競爭評估

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章 無針注射市場主要因素分析

  • 無針注射市場的驅動因素
    • 慢性病患病率上升
    • 針刺傷增加
    • 更重視疫苗接種計劃
    • 產品開發創新
  • 市場限制與挑戰
    • 設備維護成本高、訓練要求高
    • 產品設計限制
  • 市場機會
    • 加強產品設計
    • 推出針對新興市場的產品

第五章無針注射市場波特五力分析

第六章 無針注射市場佈局

  • 按產品類型
    • 填充模具
    • 預先填充
  • 按技術
    • 噴射式
    • 彈簧式
    • 其他
  • 使用性別
    • 可重複使用的
    • 一次性的
  • 按用途
    • 疫苗接種
    • 胰島素
    • 皮膚科
  • 按最終用戶
    • 醫院
    • 診所
    • 居家護理環境
  • 按地區
    • 北美無針注射市場規模（2021-2030）
    • 歐洲無針注射市場規模（2021-2030）
    • 亞太地區無針注射市場規模（2021-2030）
    • 其他地區無針注射市場規模（2021-2030年）

第七章 無針注射市場公司及產品概況

  • IntegriMedical LLC
  • INJEX Pharma GmbH
  • PharmaJet
  • CrossJect
  • European Pharma Group BV
  • National Medical Products Inc
  • Akra DermaJet
  • Meika Medical CO.
  • Basco India
  • Mystic Pharmaceuticals Inc
  • Technologies Medicales Internationales (MIT Canada) Inc.
  • INOVIO Pharmaceuticals
  • MADA MEDICAL PRODUCTS INC
  • Portal Instruments
  • D'Antonio Consultants International, Inc

第8章 KOL觀點

第9章 專案方法

第10章 DelveInsight服務內容

第 11 章關於 DelveInsight

第十二章 免責聲明與聯絡我們

Product Code: DIMDCL0070

Needle-Free Injections Market By Product Type (Fillable and Prefilled), Technology (Jet-Based, Spring-Based, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to the increased risk of communicable infections as a result of needle injuries and needle phobia among the population.

The global needle-free injection systems market was valued at USD 12.49 billion in 2023, growing at a CAGR of 14.16% during the forecast period from 2024 to 2030 to reach USD 27.65 billion by 2030. The demand for needle-free injection systems is witnessing growth due to the rising prevalence of chronic diseases, expanding number of needle-stick injuries, increasing requirement of self-injection devices, growing number of vaccination programs, and technological innovation in product development, among other factors.

Needle-Free Injections Market Dynamics:

Needle-free injection technology encompasses a wide spectrum of drug delivery systems that help in the administration of drugs through the skin using pressure combining different modes, pushing the drug through the skin, thereby eliminating the need for a hypodermic needle.

One of the major factors influencing the growth of the needle-free injection market is the rising number of needle stick injuries among patients and caregivers. As per the data provided by the World Health Organization (2019), globally more than two million occupational exposures to sharp injuries occur among 35 million healthcare workers annually.

According to the Centers for Disease Control and Prevention (CDC) and European Agency for Safety and Health at Work (EU-Occupation Safety and Health Administration) reports published in 2019, there are more than 385,000 and 1,000,000 needle stick injury cases annually among hospital healthcare workers in the United States and Europe, respectively.

Needle-stick injuries increase the risk of more than 20 types of blood-borne infectious diseases which include HIV, hepatitis C, and hepatitis B. In addition to becoming infected with blood-borne pathogens, needle stick injuries may result in chronic diseases and also cause psychological effects. Furthermore, the management of needle sticks and sharp injuries can be cost-intensive. Therefore, owing to the abovementioned factors, there is a growing need for needle-free injection systems in the market which allow for the safe administration of drugs and therapeutics as well improve the safety prospects of healthcare providers, caregivers, and patients.

Moreover, the rising prevalence of chronic diseases, such as diabetes is also one of the major factors aiding in the needle-free injections market growth.

As per statistics by the IDF Diabetes Atlas (2023), 537 million adults were living with diabetes in 2021. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. People suffering from diabetes require regular administration of insulin as one of their key treatment regimens. Many diabetes patients require multiple daily doses of insulin and often experience anxiety and pain associated with injections. Needle-free injections offer a virtually painless method for the administration of insulin by themselves in a precise manner and thereby improving the adherence to treatment and compliance by patients.

Moreover, the increased focus on providing COVID-19 vaccines to the majority of the population has also resulted in the increased demand for needle-free injection devices as many pharmaceutical companies are entering into partnerships with needle-free injection manufacturers for expanding their customer reach.

Therefore, the rising prevalence of chronic diseases, and the increasing number of needle stick injuries, coupled with the growing demand for safer self-injection devices are projected to drive the needle-free injections market growth.

However, higher requirements for training and device maintenance, limitations in the route of administration, and limitations in the variation in the design size may prove to be certain restraints to the needle-free injection market growth.

Needle-Free Injections Market Segment Analysis:

Needle-Free Injections market by Product Type (Fillable and Prefilled), Technology (Jet-Based, Spring-Based, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the application segment of the needle-free injections market, insulin delivery needle-free injections are expected to account for a significant share of the market during the forecast period. This can be attributed to the rising prevalence of diabetic population across the globe.

Diabetic patients require multiple doses of insulin in a day, which can be a daunting process for patients in case of using conventional syringes and needles for insulin administration. These devices aid in the easy administration of insulin through the nozzle orifice, which results in the generation of a fine stream of insulin. This stream then easily penetrates the skin.

Needle-free insulin injection systems offer the least resistant path for insulin administration, thereby facilitating the even spreading of the insulin in the subcutaneous layer.

Therefore, Needle-free injection devices for insulin administration are gaining popularity and are more extensively used than for other applications owing to the above-stated reason.

North America is expected to dominate the Overall Needle-Free Injections Market:

Among all the regions, North America is expected to account for the largest share of the needle-free injection market. The growing number of chronic diseases, more focus on vaccination programs, and access to better healthcare infrastructure along with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the needle-free injections market over the forecast period.

As per the data published by National Center for Immunization and Respiratory Diseases (NCIRD) under the Centers for Disease Control and Prevention 2022, influenza was associated with 9 million illnesses, 4 million medical visits, and about 10,000 hospitalizations in the United States between 2021 and 2022.

Needle-free injection systems are used in the administration of different vaccines including influenza vaccines. CDC works each year to increase the number of people who receive a flu vaccine and eliminate barriers to vaccination. As flu vaccines are commonly administered in pediatric patients, these systems help in the easy administration of vaccines to children and people suffering from needle phobia, and other apprehensions. One example of this is the PharmaJet Stratis Needle-Free Injector which is the first needleless intramuscular Jet Injector approved by the US Food and Drug Administration for the delivery of an influenza vaccine.

Moreover, the well-established healthcare infrastructure in the country which can be supported by the high per capita healthcare expenditure in the country as well as the presence of a highly aware patient population further encourages people to opt for such devices.

Therefore, the above-mentioned factors are expected to propel the growth of the North America Needle-free injections market.

Needle-Free Injections Market Key Players:

Some of the key market players operating in the needle-free injection systems market include IntegriMedical LLC, INJEX Pharma GmbH, PharmaJet Corporation, CrossJect, European Pharma Group BV, National Medical Products Inc, Akra DermaJet, Meika Medical Co, Basco India., Mystic Pharmaceuticals Inc, Technologies Medicales Internationales (MIT Canada) Inc., INOVIO Pharmaceuticals, MADA MEDICAL PRODUCTS INC., Portal Instruments, D'Antonio Consultants International, Inc and others.

Recent Developmental Activities in Needle-Free Injections Market:

In August 2022, PharmaJet and their partner Zydus Cadila announced the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the world's first Plasmid DNA Vaccine for COVID-19. The vaccine- ZyCoV-D is exclusively administered by the deployment of the PharmaJet Tropis® Needle-free Injection System.

Key Takeaways from the Needle-Free Injections Market Report Study

Market size analysis for current needle-free injections market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global needle-free injections market

Various opportunities available for the other competitor in the needle-free injections market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current needle-free injections market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for needle-free injection market growth in the coming future?

Target Audience who can be benefited from this Needle-Free Injections Market Report Study

Needle-free injection systems products providers

Research organizations and consulting companies

Needle-free injection systems -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in needle-free injections market

Various End-Users who want to know more about the needle-free injections market and the latest technological developments in the needle-free injections market

Frequently Asked Questions for Needle-Free Injections Market:

1. What is a Needle Free Injection System?

Needle-free injection technology encompasses a wide spectrum of technology that includes a wide variety of drug delivery systems that help in the administration of drugs through the skin using pressure combining different modes, pushing the drug through the skin, thereby eliminating the need for a hypodermic needle.

2. What is the market for global needle-free injections?

The global needle-free injection systems market was valued at USD 12.49 billion in 2023, growing at a CAGR of 14.16% during the forecast period from 2024 to 2030 to reach USD 27.65 billion by 2030.

3. What are the drivers for the global needle-free injections market?

The major drivers of the global needle-free injections market growth are the rising prevalence of chronic diseases, an increasing number of needle stack and sharp injuries, and a rising number of trauma cases, among other factors.

4. Who are the key players operating in the global needle-free injections market?

Some of the key market players operating in the needle-free injection systems market include IntegriMedical LLC, INJEX Pharma GmbH, PharmaJet Corporation, CrossJect, European Pharma Group BV, National Medical Products Inc, Akra DermaJet, Meika Medical Co, Basco India., Mystic Pharmaceuticals Inc, Technologies Medicales Internationales (MIT Canada) Inc., INOVIO Pharmaceuticals, MADA MEDICAL PRODUCTS INC., Portal Instruments, D'Antonio Consultants International, Inc and others.

5. Which region has the highest share in the needle-free injections market?

North America is expected to dominate the overall needle-free injections market during the forecast period, 2024 to 2030. The accumulation of the highest revenue in the market can be ascribed to the rising prevalence of chronic diseases, increased focus on vaccination programs, improving the safety of healthcare providers, and increasing collaborations between key market players in the region.

Table of Contents

1. Needle-Free Injections Market Report Introduction

2. Needle-Free Injections Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Needle-Free Injections Market Key Factors Analysis

  • 4.1. Needle-Free Injections Market Drivers
    • 4.1.1. Rising Prevalence of Chronic Diseases
    • 4.1.2. Rising Number of Needle Stick Injuries
    • 4.1.3. Growing Focus on Vaccination Programs
    • 4.1.4. Technological Innovation in Product Development
  • 4.2. Market Restraints and Challenges
    • 4.2.1. High Device Maintenance and Requirement of Training
    • 4.2.2. Limitation with Product Design
  • 4.3. Market Opportunities
    • 4.3.1. Enhancing Product Design
    • 4.3.2. Targeting Emerging Markets for Product Launches

5. Needle-Free Injections Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Needle-Free Injections Market Layout

  • 6.1. By Product Type
    • 6.1.1. Fillable
    • 6.1.2. Prefilled
  • 6.2. By Technology
    • 6.2.1. Jet-Based
    • 6.2.2. Spring-Based
    • 6.2.3. Others
  • 6.3. By Usability
    • 6.3.1. Reusable
    • 6.3.2. Disposable
  • 6.4. By Application
    • 6.4.1. Vaccine
    • 6.4.2. Insulin
    • 6.4.3. Dermatology
    • 6.4.4. Others
  • 6.5. By End-User
    • 6.5.1. Hospitals
    • 6.5.2. Clinics
    • 6.5.3. Homecare Settings
    • 6.5.4. Others
  • 6.6. By Geography
    • 6.6.1. North America Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.1.1. United States Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.1.2. Canada Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.1.3. Mexico Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.2. Europe Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.1. France Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.2. Germany Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.3. United Kingdom Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.4. Italy Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.5. Spain Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.6. Rest of Europe Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.3. Asia-Pacific Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.1. China Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.2. Japan Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.3. India Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.4. Australia Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.5. South Korea Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.6. Rest of Asia-Pacific Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.4. Rest of the World (RoW) Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.4.1. Middle East Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.4.2. Africa Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.4.3. South America Needle-Free Injections Market Size in USD million (2021-2030)

7. Needle-Free Injections Market Company and Product Profiles

  • 7.1. IntegriMedical LLC
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. INJEX Pharma GmbH
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. PharmaJet
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. CrossJect
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. European Pharma Group BV
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. National Medical Products Inc
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Akra DermaJet
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Meika Medical CO.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Basco India
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Mystic Pharmaceuticals Inc
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Technologies Medicales Internationales (MIT Canada) Inc.
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. INOVIO Pharmaceuticals
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. MADA MEDICAL PRODUCTS INC
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Portal Instruments
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. D'Antonio Consultants International, Inc
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Needle-Free Injections Market in Global (2021-2030)
  • Table 3: Needle-Free Injections Market in Global by Product Type (2021-2030)
  • Table 4: Needle-Free Injections Market in Global by Technology (2021-2030)
  • Table 5: Needle-Free Injections Market in Global by Usability (2021-2030)
  • Table 6: Needle-Free Injections Market in Global by Application (2021-2030)
  • Table 7: Needle-Free Injections Market in Global by End-User (2021-2030)
  • Table 8: Needle-Free Injections Market in Global by Geography (2021-2030)
  • Table 9: Needle-Free Injections Market in North America (2021-2030)
  • Table 10: Needle-Free Injections Market in the US (2021-2030)
  • Table 11: Needle-Free Injections Market in Canada (2021-2030)
  • Table 12: Needle-Free Injections Market in Mexico (2021-2030)
  • Table 13: Needle-Free Injections Market in Europe (2021-2030)
  • Table 14: Needle-Free Injections Market in France (2021-2030)
  • Table 15: Needle-Free Injections Market in Germany (2021-2030)
  • Table 16: Needle-Free Injections Market in the United Kingdom (2021-2030)
  • Table 17: Needle-Free Injections Market in Italy (2021-2030)
  • Table 18: Needle-Free Injections Market in Spain (2021-2030)
  • Table 19: Needle-Free Injections Market in Rest of Europe (2021-2030)
  • Table 20: Needle-Free Injections Market in Asia-Pacific (2021-2030)
  • Table 21: Needle-Free Injections Market in China (2021-2030)
  • Table 22: Needle-Free Injections Market in Japan (2021-2030)
  • Table 23: Needle-Free Injections Market in India (2021-2030)
  • Table 24: Needle-Free Injections Market in Australia (2021-2030)
  • Table 25: Needle-Free Injections Market in South Korea (2021-2030)
  • Table 26: Needle-Free Injections Market in Rest of Asia-Pacific (2021-2030)
  • Table 27: Needle-Free Injections Market in the Rest of the World (2021-2030)
  • Table 28: Needle-Free Injections Market in the Middle East (2021-2030)
  • Table 29: Needle-Free Injections Market in Africa (2021-2030)
  • Table 30: Needle-Free Injections Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Needle-Free Injections Market in Global (2021-2030)
  • Figure 3: Needle-Free Injections Market in Global by Product Type (2021-2030)
  • Figure 4: Needle-Free Injections Market in Global by Technology (2021-2030)
  • Figure 5: Needle-Free Injections Market in Global by Usability (2021-2030)
  • Figure 6: Needle-Free Injections Market in Global by Application (2021-2030)
  • Figure 7: Needle-Free Injections Market in Global by End-User (2021-2030)
  • Figure 8: Needle-Free Injections Market in Global by Geography (2021-2030)
  • Figure 9: Needle-Free Injections Market in North America (2021-2030)
  • Figure 10: Needle-Free Injections Market in the US (2021-2030)
  • Figure 11: Needle-Free Injections Market in Canada (2021-2030)
  • Figure 12: Needle-Free Injections Market in Mexico (2021-2030)
  • Figure 13: Needle-Free Injections Market in Europe (2021-2030)
  • Figure 14: Needle-Free Injections Market in France (2021-2030)
  • Figure 15: Needle-Free Injections Market in Germany (2021-2030)
  • Figure 16: Needle-Free Injections Market in the United Kingdom (2021-2030)
  • Figure 17: Needle-Free Injections Market in Italy (2021-2030)
  • Figure 18: Needle-Free Injections Market in Spain (2021-2030)
  • Figure 19: Needle-Free Injections Market in Rest of Europe (2021-2030)
  • Figure 20: Needle-Free Injections Market in Asia-Pacific (2021-2030)
  • Figure 21: Needle-Free Injections Market in China (2021-2030)
  • Figure 22: Needle-Free Injections Market in Japan (2021-2030)
  • Figure 23: Needle-Free Injections Market in India (2021-2030)
  • Figure 24: Needle-Free Injections Market in Australia (2021-2030)
  • Figure 25: Needle-Free Injections Market in South Korea (2021-2030)
  • Figure 26: Needle-Free Injections Market in Rest of Asia-Pacific (2021-2030)
  • Figure 27: Needle-Free Injections Market in the Rest of the World (2021-2030)
  • Figure 28: Needle-Free Injections Market in the Middle East (2021-2030)
  • Figure 29: Needle-Free Injections Market in Africa (2021-2030)
  • Figure 30: Needle-Free Injections Market in South America (2021-2030)
  • Figure 31: Market Drivers
  • Figure 32: Market Barriers
  • Figure 33: Marker Opportunities
  • Figure 34: PORTER'S Five Force Analysis